The latest closing stock price for Cidara Therapeutics as of January 21, 2025 is 22.18.
An investor who bought $1,000 worth of Cidara Therapeutics stock at the IPO in 2015 would have $-931 today, roughly -1 times their original investment - a -23.43% compound annual growth rate over 10 years.
The all-time high Cidara Therapeutics stock closing price was 345.20 on December 30, 2015.
The Cidara Therapeutics 52-week high stock price is 28.42, which is 28.1% above the current share price.
The Cidara Therapeutics 52-week low stock price is 10.00, which is 54.9% below the current share price.
The average Cidara Therapeutics stock price for the last 52 weeks is 14.47.
An investor who bought $1,000 worth of Cidara Therapeutics stock at the IPO in 2015 would have $-931 today, roughly -1 times their original investment - a -23.43% compound annual growth rate over 10 years.
The all-time high Cidara Therapeutics stock closing price was 345.20 on December 30, 2015.
The Cidara Therapeutics 52-week high stock price is 28.42, which is 28.1% above the current share price.
The Cidara Therapeutics 52-week low stock price is 10.00, which is 54.9% below the current share price.
The average Cidara Therapeutics stock price for the last 52 weeks is 14.47.